These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

245 related articles for article (PubMed ID: 7517866)

  • 1. Probing the interaction of the multidrug-resistance phenotype with the polypeptide ionophore gramicidin D via functional channel formation.
    Assaraf YG; Borgnia MJ
    Eur J Biochem; 1994 Jun; 222(3):813-24. PubMed ID: 7517866
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Interaction of multidrug-resistant Chinese hamster ovary cells with the peptide ionophore gramicidin D.
    Loe DW; Sharom FJ
    Biochim Biophys Acta; 1994 Feb; 1190(1):72-84. PubMed ID: 7509193
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Transport of polypeptide ionophores into proteoliposomes reconstituted with rat liver P-glycoprotein.
    Eytan GD; Borgnia MJ; Regev R; Assaraf YG
    J Biol Chem; 1994 Oct; 269(42):26058-65. PubMed ID: 7523400
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Genetic transfer of non-P-glycoprotein-mediated multidrug resistance (MDR) in somatic cell fusion: dissection of a compound MDR phenotype.
    Eijdems EW; Borst P; Jongsma AP; de Jong S; de Vries EG; van Groenigen M; Versantvoort CH; Nieuwint AW; Baas F
    Proc Natl Acad Sci U S A; 1992 Apr; 89(8):3498-502. PubMed ID: 1348862
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Competition of hydrophobic peptides, cytotoxic drugs, and chemosensitizers on a common P-glycoprotein pharmacophore as revealed by its ATPase activity.
    Borgnia MJ; Eytan GD; Assaraf YG
    J Biol Chem; 1996 Feb; 271(6):3163-71. PubMed ID: 8621716
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The role of passive transbilayer drug movement in multidrug resistance and its modulation.
    Eytan GD; Regev R; Oren G; Assaraf YG
    J Biol Chem; 1996 May; 271(22):12897-902. PubMed ID: 8662680
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The effect of ion channel blockers, immunosuppressive agents, and other drugs on the activity of the multi-drug transporter.
    Weaver JL; Szabo G; Pine PS; Gottesman MM; Goldenberg S; Aszalos A
    Int J Cancer; 1993 May; 54(3):456-61. PubMed ID: 7685326
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Differential reversal of lipophilic antifolate resistance in mammalian cells with modulators of the multidrug resistance phenotype.
    Assaraf YG; Borgnia MJ
    Anticancer Drugs; 1993 Jun; 4(3):395-406. PubMed ID: 8102912
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Role of the MDR-1-encoded multiple drug resistance phenotype in prostate cancer cell lines.
    Theyer G; Schirmböck M; Thalhammer T; Sherwood ER; Baumgartner G; Hamilton G
    J Urol; 1993 Nov; 150(5 Pt 1):1544-7. PubMed ID: 8105110
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Transfection of mu MDR 1 inhibits Na(+)-independent Cl-/-HCO3 exchange in Chinese hamster ovary cells.
    Luz JG; Wei LY; Basu S; Roepe PD
    Biochemistry; 1994 Jun; 33(23):7239-49. PubMed ID: 7911682
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Linear and cyclic peptides as substrates and modulators of P-glycoprotein: peptide binding and effects on drug transport and accumulation.
    Sharom FJ; Lu P; Liu R; Yu X
    Biochem J; 1998 Aug; 333 ( Pt 3)(Pt 3):621-30. PubMed ID: 9677321
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A unique interaction between polyamine and multidrug resistance (P-glycoprotein) transporters in cultured Chinese hamster ovary cells transfected with mouse mdr-1 gene.
    Aziz SM; Worthen DR; Yatin M; Ain KB; Crooks PA
    Biochem Pharmacol; 1998 Jul; 56(2):181-7. PubMed ID: 9698071
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Mobile ionophores are a novel class of P-glycoprotein inhibitors. The effects of ionophores on 4'-O-tetrahydropyranyl-adriamycin incorporation in K562 drug-resistant cells.
    Borrel MN; Pereira E; Fiallo M; Garnier-Suillerot A
    Eur J Biochem; 1994 Jul; 223(1):125-33. PubMed ID: 7518390
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Unidirectional fluxes of rhodamine 123 in multidrug-resistant cells: evidence against direct drug extrusion from the plasma membrane.
    Altenberg GA; Vanoye CG; Horton JK; Reuss L
    Proc Natl Acad Sci U S A; 1994 May; 91(11):4654-7. PubMed ID: 7910961
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Functional studies with a full-length P-glycoprotein cDNA encoded by the hamster pgp1 gene.
    Devine SE; Melera PW
    Cancer Chemother Pharmacol; 1994; 33(6):465-71. PubMed ID: 7907953
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Diversity of multidrug resistance in mammalian cells.
    Devine SE; Melera PW
    J Biol Chem; 1994 Feb; 269(8):6133-9. PubMed ID: 7907088
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Polyaromatic alkaloids from marine invertebrates as cytotoxic compounds and inhibitors of multidrug resistance caused by P-glycoprotein.
    Quesada AR; García Grávalos MD; Fernández Puentes JL
    Br J Cancer; 1996 Sep; 74(5):677-82. PubMed ID: 8795567
    [TBL] [Abstract][Full Text] [Related]  

  • 18. P-glycoprotein as multidrug transporter: a critical review of current multidrug resistant cell lines.
    Nielsen D; Skovsgaard T
    Biochim Biophys Acta; 1992 Jul; 1139(3):169-83. PubMed ID: 1352705
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Role of P-glycoprotein in dolastatin 10 resistance.
    Toppmeyer DL; Slapak CA; Croop J; Kufe DW
    Biochem Pharmacol; 1994 Aug; 48(3):609-12. PubMed ID: 7915113
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Probing daunorubicin accumulation defects in non-P-glycoprotein expressing multidrug-resistant cell lines using digitonin.
    Versantvoort CH; Broxterman HJ; Feller N; Dekker H; Kuiper CM; Lankelma J
    Int J Cancer; 1992 Apr; 50(6):906-11. PubMed ID: 1348241
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.